NHS National Framework for Denosumab Injection commencing 1st January 2026
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework ()
- Duration
- not specified
- Value
- £15M-£38M
- Sector
- MISCELLANEOUS
- Published
- 04 Dec 2025
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
1 buyer
- NHS England London
7 suppliers
- Accord Devon
- Celltrion Healthcare Uxbridge
- Gedeon Richter London
- Teva Castleford
- Zentiva Pharma London
- Fresenius Kabi Runcorn
- Amgen Cambridge
Description
Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026 Offer reference number: CM/TNS/25/5725 Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/TNS/25/5725/01 - Regional award for Denosumab Injection: NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months) SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months) MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months) LNW: (London) 01/01/2026 to 31/12/2026 (12 months) CM/TNS/25/5725/02 - National award for Denosumab Injection: 7NAT (National) 01/01/2026 to 31/12/2026 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England NOTE: Please see Attached Contract Copy document for the list of Unsuccessful Suppliers.
Lot Division
| 1 | |
| 2 | |
Award Detail
| 1 | Accord (Devon)
|
| 2 | Celltrion Healthcare (Uxbridge)
|
| 3 | Gedeon Richter (London)
|
| 4 | Teva (Castleford)
|
| 5 | Zentiva Pharma (London)
|
| 6 | Fresenius Kabi (Runcorn)
|
| 7 | Amgen (Cambridge)
|
CPV Codes
- None found
Indicators
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-05506a
- FTS 079939-2025